NeuroMetrix, Inc. (NASDAQ:NURO) Short Interest Up 168.4% in November

NeuroMetrix, Inc. (NASDAQ:NURO) was the recipient of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 42,400 shares, an increase of 168.4% from the October 31st total of 15,800 shares. Currently, 2.9% of the company’s stock are short sold. Based on an average daily trading volume, of 18,200 shares, the short-interest ratio is currently 2.3 days.

Wall Street Analyst Weigh In

Separately, StockNews.com started coverage on shares of NeuroMetrix in a report on Thursday. They issued a “sell” rating for the company.

NeuroMetrix Stock Performance

NASDAQ:NURO traded down $0.03 during trading hours on Friday, reaching $4.27. The company’s stock had a trading volume of 29,386 shares, compared to its average volume of 25,478. The stock has a 50 day moving average price of $4.08 and a two-hundred day moving average price of $3.84. The company has a market capitalization of $8.71 million, a P/E ratio of -0.93 and a beta of 2.29. NeuroMetrix has a 12 month low of $2.66 and a 12 month high of $4.73.

NeuroMetrix (NASDAQ:NURO) last released its quarterly earnings results on Tuesday, November 5th. The medical device company reported ($0.75) EPS for the quarter. The company had revenue of $0.59 million during the quarter. NeuroMetrix had a negative return on equity of 42.56% and a negative net margin of 203.71%. During the same period last year, the firm posted ($1.66) earnings per share.

About NeuroMetrix

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.